|Bid||57.59 x 1300|
|Ask||57.89 x 1000|
|Day's Range||57.04 - 58.89|
|52 Week Range||57.04 - 85.97|
|Beta (5Y Monthly)||0.57|
|PE Ratio (TTM)||58.12|
|Earnings Date||Oct 28, 2020|
|Forward Dividend & Yield||2.72 (4.65%)|
|Ex-Dividend Date||Dec 14, 2020|
|1y Target Est||77.42|
Chris Vermeulen, Founder and Chief Market Strategist of "The Technical Traders.com", joins Yahoo Finance's Kristin Myers to discuss the 'red flags' he sees in recent market moves.
These two drugmakers are unlikely to slash or suspend their dividend payments -- even in the midst of a recession.
Gilead Sciences has sunk to a new low for the move down today. There was a Point and Figure chart of $69 noted. In this updated daily bar chart of GILD, below, we can see that prices have been in a downward drive since late July.